Scientists attempting to peer review the paper requested vital data, and did not get it. Tonight we report a key plank of the evidence for Tamiflu's effectiveness is being called into question.
As swine flu hit the UK, the anti-viral drug Tamiflu hit the headlines, becoming the de facto first line of defence against the epidemic.
It was lauded for reducing the length and duration of flu-like illnesses and, importantly, for reducing hospitalisations.
Governments around the world stockpiled supplies. In the UK alone the estimated bill for Tamiflu is approaching half a billion pounds.
Tonight Channel 4 News can reveal that serious scientific questions are being raised over the evidence base for Tamiflu.'
Read more...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.